Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penelope Gray

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Lakartidningen|May 13, 2025
[HPV screening coverage and cancer]Joakim Dillner, Penelope Gray
The Journal of Infectious Diseases|January 22, 2025
Population-Based Age-Period-Cohort Analysis of Declining Human Papillomavirus PrevalencePenelope Gray, Jiangrong Wang, Sara Nordqvist Kleppe, et al.
International Journal of Cancer|February 13, 2025
Scientific approaches to defining HPV vaccine-induced protective immunityMatti Lehtinen, Pierre van Damme, Simon Beddows, et al.
Cell Host & Microbe|November 9, 2023
Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination effortsVille N Pimenoff, Penelope Gray, Karolina Louvanto, et al.
The Journal of Infectious Diseases|May 10, 2022
Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody ResponsesLaila Sara Arroyo Mühr, Carina Eklund, Camilla Lagheden, et al.
International Journal of Cancer|March 9, 2026
Nationwide audit of cervical cancer screening reveals unsatisfactory triage strategies and trends over time in incidence among cytology negative womenCecilia Kärrberg, Penelope Gray, Kristina Elfgren, et al.
International Journal of Cancer|June 24, 2020
Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomised HPV vaccination trial with moderate coveragePenelope Gray, Hanna Kann, Ville N Pimenoff, et al.
International Journal of Cancer|January 10, 2024
Scientific approaches toward improving cervical cancer elimination strategiesMatti Lehtinen, Laia Bruni, Miriam Elfström, et al.
Plos Medicine|June 7, 2021
Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trialPenelope Gray, Hanna Kann, Ville N Pimenoff, et al.
International Journal of Cancer|February 6, 2019
Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV)Penelope Gray, Tapio Luostarinen, Simopekka Vänskä, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Lakartidningen|May 13, 2025
[HPV screening coverage and cancer]Joakim Dillner, Penelope Gray
The Journal of Infectious Diseases|January 22, 2025
Population-Based Age-Period-Cohort Analysis of Declining Human Papillomavirus PrevalencePenelope Gray, Jiangrong Wang, Sara Nordqvist Kleppe, et al.
International Journal of Cancer|February 13, 2025
Scientific approaches to defining HPV vaccine-induced protective immunityMatti Lehtinen, Pierre van Damme, Simon Beddows, et al.
Cell Host & Microbe|November 9, 2023
Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination effortsVille N Pimenoff, Penelope Gray, Karolina Louvanto, et al.
The Journal of Infectious Diseases|May 10, 2022
Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody ResponsesLaila Sara Arroyo Mühr, Carina Eklund, Camilla Lagheden, et al.
International Journal of Cancer|March 9, 2026
Nationwide audit of cervical cancer screening reveals unsatisfactory triage strategies and trends over time in incidence among cytology negative womenCecilia Kärrberg, Penelope Gray, Kristina Elfgren, et al.
International Journal of Cancer|June 24, 2020
Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomised HPV vaccination trial with moderate coveragePenelope Gray, Hanna Kann, Ville N Pimenoff, et al.
International Journal of Cancer|January 10, 2024
Scientific approaches toward improving cervical cancer elimination strategiesMatti Lehtinen, Laia Bruni, Miriam Elfström, et al.
Plos Medicine|June 7, 2021
Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trialPenelope Gray, Hanna Kann, Ville N Pimenoff, et al.
International Journal of Cancer|February 6, 2019
Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV)Penelope Gray, Tapio Luostarinen, Simopekka Vänskä, et al.
Pageof 2